Rocco De Bernardis, Global President of OTTAVA, discusses J&J MedTech's surgical robotics system, Ottava, and its future in clinical trials. Karthik Bolisetty, senior associate at VC firm Gilde Healthcare, explores the impact of GLP-1 drugs on medical device start-ups. The CEO of Aptyx, Gregg Tobin, talks about their rebranding and the importance of a brand promise. The podcast also touches on manufacturing expertise, advancements in the TAVA surgical system, and upcoming episodes in the DeviceTalks network.